Patent · US Active

aSMase inhibitors

US8119617B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2007
Grant dateFeb 21, 2012
Priority date
Expiry dateJul 12, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/3882
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formulawherein the residues have various meanings and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.